Skip to content
Facebook
X
Instagram
YouTube
Contact
Search for:
Home
About Us
About Us
Our Staff
Our Board
Advocacy
Resources
Professional Resources
Community Resources
News/Events
Webinars
Membership
Join or Renew
Member Login
Search for:
Home
About Us
About Us
Our Staff
Our Board
Advocacy
Resources
Professional Resources
Community Resources
News/Events
Webinars
Membership
Join or Renew
Member Login
Home
About Us
About Us
Our Staff
Our Board
Advocacy
Resources
Professional Resources
Community Resources
News/Events
Webinars
Membership
Join or Renew
Member Login
Search for:
General News
General News,Latest News
Open-Label Extension Data Confirms Sustained Benefit of Acoramidis on Cardiovascular Outcomes, Including Statistically Significant Reduction in ACM Within 36 Months
Acoramidis demonstrated the earliest known time to separation in cardiovascular [...]
February 4, 2025
Previous
1
2
Page load link
Go to Top